|
1
|
Zhang JK, Yang L, Meng GL, Yuan Z, Fan J,
Li D, Chen JZ, Shi TY, Hu HM, Wei BY, et al: Protection by
salidroside against bone loss via inhibition of oxidative stress
and bone-resorbing mediators. PloS One. 8:e572512013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song B, Zhou T, Yang WL, Liu J and Shao
LQ: Programmed cell death in periodontitis: Recent advances and
future perspectives. Oral Dis. 23:609–619. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qian EW, Ge DT and Kong SK: Salidroside
protects human erythrocytes against hydrogen peroxide-induced
apoptosis. J Nat Prod. 75:531–537. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kang C, Yuan M, Wang J, Yuan M and Liu C:
Salidroside inhibits clinorotation-induced apoptosis in pulmonary
microvascular endothelial cells by regulating signaling pathway of
endoplasmic reticulum stress. FASEB J. Suppl 1:302016.
|
|
5
|
Liu S, Yu X, Hu B, Zou Y, Li J, Bo L and
Deng X: Salidroside-rescued mice from experimental sepsis through
anti-inflammatory and anti-apoptosis effects. J Surg Res.
195:277–283. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li D, Fu Y, Zhang W, Su G, Liu B, Guo M,
Li F, Liang D, Liu Z, Zhang X, et al: Salidroside attenuates
inflammatory responses by suppressing nuclear factor-κB and mitogen
activated protein kinases activation in lipopolysaccharide-induced
mastitis in mice. Inflamm Res. 62:9–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang Y, Vater C, Jacobi A, Liebers C, Zou
X and Stiehler M: Salidroside exerts angiogenic and cytoprotective
effects on human bone marro-derived endothelial progenitor cells
via Akt/mTOR/p70S6K and MAPK signalling pathways. Br J Pharmacol.
171:2440–2456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang X, Luo F, Jiang W, Zhu L, Gao J, He
H, Wei T, Gong S and Yan T: Protective activity of salidroside
against ethanol-induced gastric ulcer via the MAPK/NF-κB pathway in
vivo and in vitro. Int Immunopharmacol. 28:604–615. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xing S, Yang X, Li W, Bian F, Wu D, Chi J,
Xu G, Zhang Y and Jin S: Salidroside stimulates mitochondrial
biogenesis and protects against H2O2-induced
endothelial dysfunction. Oxid Med Cell Longev. 2014:9048342014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Zhen YF, Pu-Bu-Ci-Ren Song LG,
Kong WN, Shao TM, Li X and Chai XQ: Salidroside attenuates beta
amyloid-induced cognitive deficits via modulating oxidative stress
and inflammatory mediators in rat hippocampus. Behav Brain Res.
244:70–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li L, Qu Y, Jin X, Guo XQ, Wang Y, Qi L,
Yang J, Zhang P and Li LZ: Protective effect of salidroside against
bone loss via hypoxia-inducible factor-1α pathway-induced
angiogenesis. Sci Rep. 6:321312016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Z, Li X, Simoneau AR, Jafari M and Zi
X: Rhodiola rosea extracts and salidroside decrease the growth of
bladder cancer cell lines via inhibition of the mTOR pathway and
induction of autophagy. Mol Carcinog. 51:257–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang J, Li JZ, Lu AX, Zhang KF and Li BJ:
Anticancer effect of salidroside on A549 lung cancer cells through
inhibition of oxidative stress and phospho-p38 expression. Oncol
Lett. 7:1159–1164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Di Benedetto A, Gigante I, Colucci S and
Grano M: Periodontal disease: Linking the primary inflammation to
bone loss. Clin Dev Immunol. 2013:5037542013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pacios S, Andriankaja O, Kang J, Alnammary
M, Bae J, de Brito Bezerra B, Schreiner H, Fine DH and Graves DT:
Bacterial infection increases periodontal bone loss in diabetic
rats through enhanced apoptosis. Am J Pathol. 183:1928–1935. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tonetti MS and Van Dyke TE: Working group
1 of the joint EFP/AAP workshop: Periodontitis and atherosclerotic
cardiovascular disease: Consensus report of the Joint EFP/AAP
workshop on periodontitis and systemic diseases. J Periodontol. 84
4 Suppl:S24–S29. 2013. View Article : Google Scholar
|
|
17
|
Lee SI, Yi JK, Bae WJ, Lee S, Cha HJ and
Kim EC: Thymosin beta-4 suppresses osteoclastic differentiation and
inflammatory responses in human periodontal ligament cells. Plos
One. 11:e01467082016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hasegawa M, Yamato M, Kikuchi A, Okano T
and Ishikawa I: Human periodontal ligament cell sheets can
regenerate periodontal ligament tissue in an athymic rat model.
Tissue Eng. 11:469–478. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nagatomo K, Komaki M, Sekiya I, Sakaguchi
Y, Noguchi K, Oda S, Muneta T and Ishikawa I: Stem cell properties
of human periodontal ligament cells. J Periodontal Res. 41:303–310.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han J, Meng HX, Tang JM, Li SL, Tang Y and
Chen ZB: The effect of different platelet-rich plasma
concentrations on proliferation and differentiation of human
periodontal ligament cells in vitro. Cell Prolif. 40:241–252. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia L, Zhang Z, Chen L, Zhang W, Zeng D,
Zhang X, Chang J and Jiang X: Proliferation and osteogenic
differentiation of human periodontal ligament cells on akermanite
and β-TCP bioceramics. Eur Cell Mater. 22:68–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giuliani N, Morandi F, Tagliaferri S,
Lazzaretti M, Bonomini S, Crugnola M, Mancini C, Martella E,
Ferrari L, Tabilio A and Rizzoli V: The proteasome inhibitor
bortezomib affects osteoblast differentiation in vitro and in vivo
in multiple myeloma patients. Blood. 110:334–338. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu X, Tian J, Zhang L, Chen Y and Hao Q:
Involvement of microRNA-93, a new regulator of PTEN/Akt signaling
pathway, in regulation of chemotherapeutic drug cisplatin
chemosensitivity in ovarian cancer cells. FEBS Lett. 586:1279–1286.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lv C, Huang Y, Liu ZX, Yu D and Bai ZM:
Salidroside reduces renal cell carcinoma proliferation by
inhibiting JAK2/STAT3 signaling. Cancer Biomark. 17:41–47. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dai J, Peng L, Fan K, Wang H, Wei R, Ji G,
Cai J, Lu B, Li B, Zhang D, et al: Osteopontin induces angiogenesis
through activation of PI3K/AKT and ERK1/2 in endothelial cells.
Oncogene. 28:3412–3422. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Waseem T, Duxbury M, Ashley SW and
Robinson MK: Ghrelin promotes intestinal epithelial cell
proliferation through PI3K/Akt pathway and EGFR trans-activation
both converging to ERK 1/2 phosphorylation. Peptides. 52:113–121.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ishii A, Furusho M and Bansal R: Sustained
activation of ERK1/2 MAPK in oligodendrocytes and schwann cells
enhances myelin growth and stimulates oligodendrocyte progenitor
expansion. J Neurosci. 33:175–186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang N, Hui L, Wang Y, Yang H and Jiang X:
SOX2 promotes the migration and invasion of laryngeal cancer cells
by induction of MMP-2 via the PI3K/Akt/mTOR pathway. Oncol Rep.
31:2651–2659. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Serra V, Scaltriti M, Prudkin L, Eichhorn
PJ, Ibrahim YH, Chandarlapaty S, Markman B, Rodriguez O, Guzman M,
Rodriguez S, et al: PI3K inhibition results in enhanced HER
signaling and acquired ERK dependency in HER2-overexpressing breast
cancer. Oncogene. 30:2547–2557. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martin P and Pognonec P: ERK and cell
death: Cadmium toxicity, sustained ERK activation and cell death.
FEBS J. 277:39–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Roux PP and Blenis J: ERK and p38
MAPK-activated protein kinases: A family of protein kinases with
diverse biological functions. Microbiol Mol Biol Rev. 68:320–344.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
An S, Huang X, Gao Y, Ling J, Huang Y and
Xiao Y: FGF-2 induces the proliferation of human periodontal
ligament cells and modulates their osteoblastic phenotype by
affecting Runx2 expression in the presence and absence of
osteogenic inducers. Int J Mol Med. 36:705–711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Padial-Molina M, Volk SL and Rios HF:
Periostin increases migration and proliferation of human
periodontal ligament fibroblasts challenged by tumor necrosis
factor-α and Porphyromonas gingivalis lipopolysaccharides. J
Periodontal Res. 49:405–414. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Booth SL, Centi A, Smith SR and Gundberg
C: The role of osteocalcin in human glucose metabolism: Marker or
mediator? Nat Rev Endocrinol. 9:43–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wei J, Hanna T, Suda N, Karsenty G and
Ducy P: Osteocalcin promotes β-cell proliferation during
development and adulthood through Gprc6a. Diabetes. 63:1021–1031.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chang D, Xu H, Guo Y, Jiang X, Liu Y, Li
K, Pan C, Yuan M, Wang J, Li T and Liu C: Simulated microgravity
alters the metastatic potential of a human lung adenocarcinoma cell
line. In Vitro Cell Dev Biol Anim. 49:170–177. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kaw A, Fraga D and Fischer C: Effect of
osteocalcin on human beta cell proliferation and function and its
role on insulin secretion. Pancreatol. 13 Suppl:S642013. View Article : Google Scholar
|
|
38
|
Gerard K and Ducy PF:
Undercarboxylated/uncarboxylated osteocalcin increases beta-cell
proliferation, insulin secretion, insulin sensitivity, glucose
tolerance and decreases fat mass. Patent AU2007294732. Filed
September 13, 2007; issued April 23. 2009.
|
|
39
|
Liu J and Yang J: Uncarboxylated
osteocalcin inhibits high glucose-induced ROS production and
stimulates osteoblastic differentiation by preventing the
activation of PI3K/Akt in MC3T3-E1 cells. Int J Mol Med.
37:173–181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Han Y, Xu G, Zhang J, Yan M, Li X, Ma B,
Jun L, Wang SJ and Tan J: Leptin induces osteocalcin expression in
ATDC5 cells through activation of the MAPK-ERK1/2 signaling
pathway. Oncotarget. 7:64021–64029. 2016. View Article : Google Scholar : PubMed/NCBI
|
